by admin | May 18, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
WASHINGTON DC, DISTRICT OF COLUMBIA, UNITED STATES, May 17, 2023/ EINPresswire.com/ — The historic first “Regenerative & Rejuvenative Medicine Industry Annual Congress and Scientific Trade Show (R2M) ™” was announced today by officials. R2M will...
by admin | May 17, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
baby girl who developed a life-threatening brain condition was successfully treated before she was born—and is now a healthy seven-week-old. By Jessica Hamzelou – MIT Technology Review She doesn’t know it yet, but a baby girl living somewhere near Boston has...
by admin | May 16, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by John Cumbers – Forbes After being at the helm for over a decade of internet juggernaut Google GOOG -0.8%, former CEO Eric Schmidt has switched gears and one of his latest activities is being an advocate for the fast-growing US bioeconomy, which is valued at...
by admin | May 15, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Innovation Quarter From developing the world’s first lab-grown organ (a bladder) to the body-on-a-chip platform used for drug toxicity testing and personalized medicine, Winston-Salem-based scientists have been integral to cutting-edge regenerative medicine...
by admin | May 15, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Michael Irving – News Atlas Scientists in Canada have developed a new technique that may one day help restore some sight to patients with inherited vision impairment. The regenerative therapy works by expressing genes that convert dormant cells into new...
by admin | May 14, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Physician’s Weekly Mesenchymal stem cell-neural progenitor therapy (MSC-NPs) are bone marrow-derived cells with trophic and immunomodulatory properties. Their therapeutic potential in MS was evaluated in a randomized, double-blind, placebo-controlled phase 2...
